What question did this study set out to answer?

This research investigates the role of ARID4B in enhancing lung adenocarcinoma malignancy through GPRC5C activation.

March 6, 2026Open Access

ARID4B Promotes Lung Adenocarcinoma Malignancy by Activating GPRC5C transcription via Histone H1 Displacement

This research investigates the role of ARID4B in enhancing lung adenocarcinoma malignancy through GPRC5C activation.
Examined the role of ARID4B in transcription regulation
Studied the activation of GPRC5C
Evaluated effects on epithelial-mesenchymal transition (EMT) and stemness
ARID4B was found to activate GPRC5C transcription
Activation led to increased malignancy in lung adenocarcinoma
GPRC5C activation was linked to enhanced EMT and cancer stemness

ARID4B promotes LUAD malignancy by transcriptionally activating GPRC5C, thereby driving EMT and cancer stemness.

Demander à l'IA

Bookmark

View Full Paper

Huang et al. (Wed,) studied this question.

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

Demander à l'IA

Bookmark

View Full Paper